Physician

James Christopher Goetz, M.D.

According to 2025 Medicare claims, James Goetz, M.D. (NPI: 1700827714) practices hospitalist in the Huntington-Ashland, WV-KY-OH market, with the plurality of this provider's patient population coming from Greenup, KY. This provider's primary affiliated billing organization is KINGS DAUGHTERS MEDICAL SPECIALTIES INC (NPI: 1669791323; TIN: 264183569) and primary practice location at 41101-2843.

Goetz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 436 traditional Medicare patients, billed 1,119 HCPCS/CPT codes, and received $89,573 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 668 prescription claims across 286 beneficiaries totaling $39,464 in drug costs, led by Ceftriaxone (Ceftriaxone Sodium). 2023 DME data shows 69 claims. Open Payments data shows 1 records totaling $13. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $318,863 to $89,573. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $886,435 to $39,464. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $31,759 to $2,572.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	778	11,166	$318,863
2016	812	14,558	$370,142
2017	1,135	4,001	$186,220
2018	1,018	2,191	$164,670
2019	1,005	2,379	$182,525
2020	860	2,046	$168,930
2021	691	1,548	$124,314
2022	660	1,524	$116,865
2023	527	1,281	$101,602
2024	436	1,119	$89,573

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	712	16,035	$886,435
2016	742	15,436	$862,351
2017	845	7,042	$455,499
2018	343	765	$41,755
2019	302	666	$33,168
2020	201	505	$65,346
2021	241	568	$50,841
2022	263	604	$31,527
2023	268	555	$44,242
2024	286	668	$39,464

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	299	1,255	$40,586
2016	269	1,155	$23,486
2017	135	598	$12,287
2018	23	184	$5,813
2019	12	141	$8,082
2020	N/R	138	$6,234
2021	24	164	$9,439
2022	N/R	114	$6,471
2023	N/R	69	$5,574
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	154	158	$124
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	127	275	$87
99239	Hospital discharge day management, more than 30 minutes	193	206	$84
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	222	460	$58

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ceftriaxone	Ceftriaxone Sodium	15	106	$536
Pantoprazole Sodium	Pantoprazole Sodium	55	1,656	$466
Cefuroxime	Cefuroxime Axetil	30	156	$427
Doxycycline Monohydrate	Doxycycline Monohydrate	25	152	$158
Atorvastatin Calcium	Atorvastatin Calcium	16	1,320	$144

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$13	ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James Christopher Goetz, M.D.?

Tedicare shows public-source Medicare data for James Christopher Goetz, M.D. (NPI 1700827714), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Christopher Goetz, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James Christopher Goetz, M.D.?

James Christopher Goetz, M.D. is linked to KINGS DAUGHTERS MEDICAL SPECIALTIES INC (billing NPI 1669791323) in the available physician profile data.

Does James Christopher Goetz, M.D. have Open Payments data?

James Christopher Goetz, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.